Eupraxia 制药 EPRX
$6.89 +$0.29 (+4.39%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.89 0.00%
开盘$6.60
昨收$6.60
当日区间$6.52 – $6.89
成交量585.1K
市值$455.25M
市盈率（TTM）–
股息率–
EPRX 相关新闻
匹配 Eupraxia Pharmaceuticals 或代码 EPRX 的头条新闻，按最新排序。
- Stifel Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $25
- Wedbush Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
- H.C. Wainwright Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX)
- H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $11
- William Blair Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating
- LifeSci Capital Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $16
- A Quick Look at Today's Ratings for Eupraxia Pharmaceuticals(EPRX.US), With a Forecast Between $11 to $25
- Cantor Fitzgerald Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $19
- Oppenheimer Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
- Oppenheimer Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $17
- Craig-Hallum Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
- H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)
- Stifel Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $25
- William Blair Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
- H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Cuts Target Price to $11 负面
暂无评论——快来第一个聊聊 EPRX。
登录后参与讨论。